chitosan has been researched along with Wet Macular Degeneration in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Almeida, TC; Arribada, RG; Da Silva, FHR; Da Silva, GN; Da Silva, GR; De Vasconcelos Quaresma, A; Dos Reis Teixeira, A; Fialho, SL; Lima De Moura, SA; Neto, JT; Reis, JSD; Silva-Cunha, A | 1 |
1 other study(ies) available for chitosan and Wet Macular Degeneration
| Article | Year |
|---|---|
Sodium butyrate-loaded nanoparticles coated with chitosan for the treatment of neovascularization in age-related macular degeneration: Ocular biocompatibility and antiangiogenic activity.
Topics: Angiogenesis Inhibitors; Animals; Butyric Acid; Chitosan; Humans; Nanoparticles; Rats; Solvents; Wet Macular Degeneration | 2022 |